Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00026351
Status:
COMPLETED
Last Update Posted:
2013-02-04
First Post:
2001-11-09
Brief Title:
Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkins Lymphoma or Chronic Lymphocytic Leukemia
Sponsor:
Pharmatech Oncology
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000069021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pharmatech Oncology
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None